Fundz

Who to call at NurExone Biologic, and when

Fundz watches for the moments NurExone Biologic starts buying, and tells you who to reach.

  • An alert the day NurExone Biologic raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NurExone Biologic, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NurExone Biologic. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

NurExone Biologic Enters 5-Year Manufacturing Partnership with Made Scientific for Bone-Marrow-Derived Exosomes.

Aug 22, 2026

Contract Type

partnership

HaifaBiotechnology

Description

NurExone Biologic has signed a binding letter of intent with Made Scientific for the exclusive manufacturing and aseptic filling of bone-marrow-derived exosomes. This partnership will consolidate their GMP manufacturing strategy and is set to produce its first batches by mid-2027.

Company Information

Company

NurExone Biologic

Location

MINUS 1 ENTRY, GROUND FLOOR OF BLDG B

Haifa, Haifa District, Israel

About

NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System. The breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries.

Related People

Lior
Likely contact at this company
••••••••@••••••••

See Lior's verified email →

Limor
Senior decision-maker at this company
••••••••@••••••••

See Limor's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NurExone Biologic's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

NurExone Biologic signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.